Displaying 151 - 180 of 180 results
Released Company Title Industry Topic
16 Dec 2021
15:00 CET
BERGENBIO BerGenBio ASA: Notice of Extraordinary General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Dec 2021
07:30 CET
BERGENBIO BerGenBio announces exclusive in-license of key intellectual property rights from UT Southwestern Medical Center 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Dec 2021
07:43 CET
BERGENBIO BerGenBio to present at DNB Nordic Healthcare Conference 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
13 Dec 2021
15:00 CET
BERGENBIO BERGENBIO PRESENTS UPDATED BEMCENTINIB AML DATA AT ASH 2021 MEETING 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
17 Nov 2021
17:51 CET
BERGENBIO BerGenBio ASA: Share capital increase 20103010 Biotechnology Total number of voting rights and capital
16 Nov 2021
07:00 CET
BERGENBIO BERGENBIO ASA: RESULTS FOR THE THIRD QUARTER OF 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Nov 2021
16:29 CET
BERGENBIO BerGenBio ASA: Increase of share capital, exercise of share options 20103010 Biotechnology Total number of voting rights and capital
09 Nov 2021
14:05 CET
BERGENBIO BERGENBIO RECEIVES FDA FAST TRACK DESIGNATION FOR BEMCENTINIB IN STK11-MUTATED ADVANCED/METASTATIC NON-SMALL LUNG CANCER (NSCLC) 20103010 Biotechnology Inside information
09 Nov 2021
14:00 CET
BERGENBIO BERGENBIO PRESENTS PRE-CLINICAL AND CLINICAL DATA ON BEMCENTINIB IN STK11-POSITIVE NSCLC AT SITC ANNUAL MEETING 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Nov 2021
15:11 CET
BERGENBIO BERGENBIO TO PRESENT UPDATED BEMCENTINIB AML DATA AT ASH 2021 MEETING 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Nov 2021
07:00 CET
BERGENBIO BERGENBIO ASA: INVITATION TO THIRD QUARTER 2021 RESULTS PRESENTATION AND WEBCAST 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Oct 2021
10:24 CEST
BERGENBIO BerGenBio ASA: Share capital increase 20103010 Biotechnology Total number of voting rights and capital
01 Oct 2021
15:20 CEST
BERGENBIO BERGENBIO ANNOUNCES POSTER PRESENTATION AT SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 Sep 2021
17:05 CEST
BERGENBIO BerGenBio ASA: Increase of share capital, exercise of share options 20103010 Biotechnology Total number of voting rights and capital
07 Sep 2021
19:21 CEST
BERGENBIO BERGENBIO COMPLETES RECRUITMENT OF PHASE II AML STUDY (BGBC003) 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Sep 2021
09:36 CEST
BERGENBIO BerGenBio ASA: Share capital increase 20103010 Biotechnology Total number of voting rights and capital
31 Aug 2021
17:55 CEST
BERGENBIO BerGenBio ASA: Increase of share capital, exercise of share options 20103010 Biotechnology Total number of voting rights and capital
26 Aug 2021
17:25 CEST
BERGENBIO BerGenBio ASA: Share capital increase 20103010 Biotechnology Total number of voting rights and capital
23 Aug 2021
18:42 CEST
BERGENBIO BerGenBio ASA: Increase of share capital, exercise of share options 20103010 Biotechnology Total number of voting rights and capital
22 Aug 2021
20:30 CEST
BERGENBIO BERGENBIO ASA: LEADERSHIP CHANGE 20103010 Biotechnology Inside information
22 Aug 2021
20:30 CEST
BERGENBIO BERGENBIO ASA: LEDERSKIFTE 20103010 Biotechnology Innsideinformasjon
17 Aug 2021
07:00 CEST
BERGENBIO BERGENBIO ASA: RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF 2021 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
06 Aug 2021
08:00 CEST
BERGENBIO BERGENBIO ANNOUNCES CHANGES TO SENIOR MANAGEMENT 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Aug 2021
07:00 CEST
BERGENBIO BERGENBIO ASA: INVITATION TO PRESENTATION OF SECOND QUARTER AND HALF YEAR 2021 RESULTS 20103010 Biotechnology Non-regulatory press releases
21 Jul 2021
07:00 CEST
BERGENBIO BERGENBIO COVID-19 DATA PRESENTED AT THE ANNUAL AMERICAN SOCIETY FOR VIROLOGY 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
12 Jul 2021
14:12 CEST
BERGENBIO BERGENBIO PRESENTS ENCOURAGING COMBINED DATA FOR BEMCENTINIB FROM TWO PHASE II COVID-19 STUDIES AT ECCMID 20103010 Biotechnology Inside information
10 Jul 2021
13:00 CEST
BERGENBIO PRECLINICAL BEMCENTINIB AND TILVESTAMAB DATA PRESENTED AT EAU 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Jun 2021
07:00 CEST
BERGENBIO BERGENBIO PRESENTING COVID-19 DATA IN LATE-BREAKING ABSTRACT PRESENTATION AT ECCMID 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Jun 2021
07:00 CEST
BERGENBIO BERGENBIO TO PRESENT AT 4th ANNUAL NEXT GEN IMMUNO-ONCOLOGY VIRTUAL CONGRESS 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Jun 2021
12:41 CEST
BERGENBIO BerGenBio ASA: Share capital increase 20103010 Biotechnology Total number of voting rights and capital